Theraflu Severe Cold Relief Nighttime - NDC Database
5 records found
Page:
0067-0101 Dec 01, 2023
Theraflu Severe Cold Relief Nighttime Oral Powder, for Solution by Glaxosmithkline Consumer Healthcare Holdings (Us) LLC
Theraflu Severe Cold Relief Nighttime Oral Powder, for Solution by Glaxosmithkline Consumer Healthcare Holdings (Us) LLC
0067-6800 Jan 20, 2022
Theraflu Severe Cold Relief Nighttime Oral Powder by Glaxosmithkline Consumer Healthcare Holdings (Us) LLC
Theraflu Severe Cold Relief Nighttime Oral Powder by Glaxosmithkline Consumer Healthcare Holdings (Us) LLC
0067-6801 Jan 20, 2022
Theraflu Severe Cold Relief Nighttime Oral Powder by Glaxosmithkline Consumer Healthcare Holdings (Us) LLC
Theraflu Severe Cold Relief Nighttime Oral Powder by Glaxosmithkline Consumer Healthcare Holdings (Us) LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.